RT @Tevogen: 📰 globenewswire.com/news-release/2…
Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement
Up to $28.6 million in…
Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement
Up to $28.6 million in…
0
6
0
RT @Tevogen: 📰 globenewswire.com/news-release/2…
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
🔹Both previousl…
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
🔹Both previousl…
0
5
0
RT @Tevogen: 📰 globenewswire.com/news-release/2…
Tevogen is a healthcare enterprise focused on improving the affordability and accessibility of life…
Tevogen is a healthcare enterprise focused on improving the affordability and accessibility of life…
0
6
0
RT @TevogenBio: Tevogen Bio Announces 2026 Annual Meeting of Stockholders
📰 globenewswire.com/news-release/2…
The Annual Meeting will be held virtu…
📰 globenewswire.com/news-release/2…
The Annual Meeting will be held virtu…
0
5
0
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
📰 globenewswire.com/news-release/2…
The Annual Meeting will be held virtually. Stockholders of record as of July 23, 2026 will be entitled to receive notice of and vote at the Annual Meeting or any adjournment thereof.
$TVGN
📰 globenewswire.com/news-release/2…
The Annual Meeting will be held virtually. Stockholders of record as of July 23, 2026 will be entitled to receive notice of and vote at the Annual Meeting or any adjournment thereof.
$TVGN
0
6
8
562
RT @TevogenBio: 🇺🇸 Happy Fourth of July from Tevogen. Today, we celebrate independence, opportunity, and the shared pursuit of a healthier…
0
3
0
RT @TevogenBio: A little #TBT to a day we will never forget.
We are proud of how far we have come, and even more energized by where we are…
We are proud of how far we have come, and even more energized by where we are…
0
4
0
RT @DrRyanSaadi: The most powerful pharmacy in the world isn’t on a street corner. It’s already inside our veins. @TevogenBio - #Tcell
🌐 h…
🌐 h…
0
5
0
RT @TevogenBio: 📰 globenewswire.com/news-release/2…
“Tevogen’s evaluation of potential MSO and CRO acquisitions reflects a disciplined approach to b…
“Tevogen’s evaluation of potential MSO and CRO acquisitions reflects a disciplined approach to b…
0
4
0
RT @TevogenBio: At JPM43 Mittul Mehta, @Head_TevogenAI and @drhew
Chief Medical Officer & VP of Healthcare at
@Microsoft discussed AI in Bi…
Chief Medical Officer & VP of Healthcare at
@Microsoft discussed AI in Bi…
0
4
0
RT @TevogenBio: Dr. Neal Flomenberg, Chief Scientific Officer, and Lori Grosso, Clinical Lead, discussed @TevogenBio's goal of making cytot…
0
1
0
3
RT @TevogenBio: 📰 tevogen.com/press-release/…
“Capital discipline and preserving the integrity of our capital structure are core priorities fo…
“Capital discipline and preserving the integrity of our capital structure are core priorities fo…
0
1
0
3
RT @TevogenBio: 📰 tevogen.com/press-release/…
“We anticipate this opportunity together with previously announced CRO evaluation and other stra…
“We anticipate this opportunity together with previously announced CRO evaluation and other stra…
0
3
0
RT @TevogenBio: 📰 tevogen.com/press_release/…
🔹Loss from operations declined 51%, from $53.6 million in 2024 to $26.1 million in 2025.
🔹Q1 20…
🔹Loss from operations declined 51%, from $53.6 million in 2024 to $26.1 million in 2025.
🔹Q1 20…
0
5
0
RT @TevogenBio: 📰 tevogen.com/press_release/…
“Having The Patel Family, LLP continue to support Tevogen reflects a shared belief in both our m…
“Having The Patel Family, LLP continue to support Tevogen reflects a shared belief in both our m…
0
3
0
RT @TevogenBio: 📰 globenewswire.com/news-release/2…
“Advancing PredicTcell toward completion marks an important milestone in our AI strategy,” said…
“Advancing PredicTcell toward completion marks an important milestone in our AI strategy,” said…
0
4
0
RT @TevogenBio: 🔗 databricks.com/blog/tevogen-b…
As part of our ongoing work on PredicTcell™, we’ve been leveraging scalable data infrastructure…
As part of our ongoing work on PredicTcell™, we’ve been leveraging scalable data infrastructure…
0
4
0
RT @TevogenBio: 📰 globenewswire.com/news-release/2…
With compliance restored, Tevogen continues to advance its evolution into a diversified, fully i…
With compliance restored, Tevogen continues to advance its evolution into a diversified, fully i…
0
1
0
Tevogen Bio retweeted
📰 globenewswire.com/news-release/2…
@DrRyanSaadi, Founder and CEO of Tevogen stated, "Long COVID is a clinical emergency affecting hundreds of millions of people globally. Our proof-of-concept data demonstrated that none of the patients treated with TVGN 489 for acute infection developed d HLA coverage now reaching 65% of the U.S. population, and potential digital health acquisitions move us toward building the infrastructure needed to launch our next clinical phase with precision and scale."
$TVGN #LongCOVID #TCellTherapy #PublicHealth #LongCOVIDAwareness #LongCOVIDAwarenessMonth
@DrRyanSaadi, Founder and CEO of Tevogen stated, "Long COVID is a clinical emergency affecting hundreds of millions of people globally. Our proof-of-concept data demonstrated that none of the patients treated with TVGN 489 for acute infection developed d HLA coverage now reaching 65% of the U.S. population, and potential digital health acquisitions move us toward building the infrastructure needed to launch our next clinical phase with precision and scale."
$TVGN #LongCOVID #TCellTherapy #PublicHealth #LongCOVIDAwareness #LongCOVIDAwarenessMonth
0
3
5
341
RT @TevogenBio: 📰 globenewswire.com/news-release/2…
“The potential acquisition of a CRO could introduce revenue-generating service capabilities whil…
“The potential acquisition of a CRO could introduce revenue-generating service capabilities whil…
0
1
0
25